64628-73-5 Usage
Description
3-Chloro-4-(trifluoromethoxy)aniline is an organic compound that features a chlorine atom at the 3-position and a trifluoromethoxy group at the 4-position of the aniline molecule. It is a versatile intermediate in the synthesis of various chemical compounds.
Uses
Used in Chemical Synthesis Industry:
3-Chloro-4-(trifluoromethoxy)aniline is used as a primary intermediate for the synthesis of a range of chemical compounds, including pharmaceuticals, agrochemicals, and specialty chemicals. Its unique functional groups allow for a variety of chemical reactions, making it a valuable building block in the development of new molecules with specific properties and applications.
Additionally, it can be used as a secondary intermediate in the synthesis of more complex molecules, where it may be incorporated into larger structures or used to modify existing compounds to enhance their performance or introduce new functionalities. This dual role highlights the importance of 3-Chloro-4-(trifluoromethoxy)aniline in the chemical synthesis industry, as it contributes to the creation of innovative and diverse products.
Check Digit Verification of cas no
The CAS Registry Mumber 64628-73-5 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 6,4,6,2 and 8 respectively; the second part has 2 digits, 7 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 64628-73:
(7*6)+(6*4)+(5*6)+(4*2)+(3*8)+(2*7)+(1*3)=145
145 % 10 = 5
So 64628-73-5 is a valid CAS Registry Number.
64628-73-5Relevant articles and documents
QUINAZOLINE DERIVATIVE, PREPARATION METHOD THEREFOR, AND PHARMACEUTICAL COMPOSITION AND APPLICATION THEREOF
-
Paragraph 0224; 0225, (2017/07/14)
Disclosed are a quinazoline derivative, a preparation method therefor, and a pharmaceutical composition and an application thereof. The present invention provides a compound represented by general formula I, a stereoisomer thereof and a pharmaceutical acceptable salt or a solvate thereof. The quinazoline derivative of the present invention has a unique chemical structure, is characterized by irreversibly inhibiting EGFR tyrosine kinase, has high biological activity, apparently improves the inhibiting effect on the EGFR tyrosine kinase, has quite strong tumor inhibiting effect on tumor cells and a transplantation tumor pathological model of animal tumors, and has good market developing prospects.
